Skip to main content
Top
Published in: Obesity Surgery 4/2019

01-04-2019 | Bariatric Surgery | Original Contribution

Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB

Authors: Tingfeng Wang, Yunlong Shen, Zhengdong Qiao, Yueqian Wang, Peng Zhang, Bo Yu

Published in: Obesity Surgery | Issue 4/2019

Login to get access

Abstract

Background

Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) has launched a huge challenge to classic Roux-en-Y gastric bypass (RYGB). Our objective was to compare diabetes remission and micronutrient deficiency in a mildly obese diabetic rat model undergoing SADI-S versus RYGB.

Methods

Thirty adult male mildly obese diabetic rats were randomly assigned to sham (S), SADI-S, and RYGB groups. Body weight, food intake, fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), plasma insulin, GLP-1, and ghrelin levels were measured at indicated time points. Meanwhile, insulin sensitivity and pancreatic β cell function were assessed during OGTT. Finally, plasma micronutrient evaluation and islet β cell mass analysis were performed after all animals were sacrificed.

Results

As compared to sham, the SADI-S and RYGB groups achieved almost equivalent efficacy in caloric restriction and FPG control without excessive weight loss. During OGTT, the SADI-S and RYGB groups also provided comparable effects on glycemic excursion, insulin sensitivity, and β cell function; however, only rats in the RYGB group showed significant changes in gut hormones, whereas the three groups were found to exhibit no significant difference in β cell mass. In addition, only vitamin E in the RYGB group was deficient as compared with the SADI-S and S groups.

Conclusion

In mildly obese diabetic rat, SADI-S and RYGB procedures have comparable efficacy in diabetes remission and risk of micronutrient deficiency. These data show that each of the surgery accomplishes diabetes improvements through both overlapping and distinct mechanisms requiring further investigation.
Literature
1.
go back to reference Ma RC, Lin X, Jia W. Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol. 2014;2(12):980–91.CrossRef Ma RC, Lin X, Jia W. Causes of type 2 diabetes in China. Lancet Diabetes Endocrinol. 2014;2(12):980–91.CrossRef
2.
go back to reference Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.CrossRef Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101.CrossRef
3.
go back to reference Zhang L, Qiao Q, Tuomilehto J, et al. Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study. Diabetes Metab Res Rev. 2009;25(6):549–57.CrossRefPubMed Zhang L, Qiao Q, Tuomilehto J, et al. Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: the DECODA study. Diabetes Metab Res Rev. 2009;25(6):549–57.CrossRefPubMed
4.
go back to reference Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12(6):1144–62.CrossRefPubMed Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Surg Obes Relat Dis. 2016;12(6):1144–62.CrossRefPubMed
5.
go back to reference Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17(12):1614–8.CrossRefPubMed Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, et al. Proximal duodenal-ileal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg. 2007;17(12):1614–8.CrossRefPubMed
6.
go back to reference Brown WA, Ooi G, Higa K, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS) IFSO position statement. Obes Surg. 2018;28:1207–16.CrossRefPubMed Brown WA, Ooi G, Higa K, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS) IFSO position statement. Obes Surg. 2018;28:1207–16.CrossRefPubMed
8.
go back to reference Mitzman B, Cottam D, Goriparthi R, et al. Stomach intestinal pylorus sparing (SIPS) surgery for morbid obesity: retrospective analyses of our preliminary experience. Obes Surg. 2016;26(9):2098–2104.9.CrossRefPubMed Mitzman B, Cottam D, Goriparthi R, et al. Stomach intestinal pylorus sparing (SIPS) surgery for morbid obesity: retrospective analyses of our preliminary experience. Obes Surg. 2016;26(9):2098–2104.9.CrossRefPubMed
9.
go back to reference Surve A, Cottam D, Sanchez-Pernaute A, et al. The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience. Surg Obes Relat Dis. 2018;14(5):594–601.CrossRefPubMed Surve A, Cottam D, Sanchez-Pernaute A, et al. The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience. Surg Obes Relat Dis. 2018;14(5):594–601.CrossRefPubMed
10.
go back to reference Cottam A, Cottam D, Zaveri H, et al. An analysis of mid-term complications, weight loss, and type 2 diabetes resolution of stomach intestinal pylorus-sparing surgery (SIPS) versus Roux-En-Y gastric bypass (RYGB) with three-year follow-up. Obes Surg. 2018;28:2894–902.CrossRefPubMed Cottam A, Cottam D, Zaveri H, et al. An analysis of mid-term complications, weight loss, and type 2 diabetes resolution of stomach intestinal pylorus-sparing surgery (SIPS) versus Roux-En-Y gastric bypass (RYGB) with three-year follow-up. Obes Surg. 2018;28:2894–902.CrossRefPubMed
11.
go back to reference Hu C, Zhang G, Sun D, et al. Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model. Obes Surg. 2013;23(9):1436–44.CrossRefPubMed Hu C, Zhang G, Sun D, et al. Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model. Obes Surg. 2013;23(9):1436–44.CrossRefPubMed
12.
go back to reference Wang T, Zhang P, Zhang X, et al. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats. Surg Obes Relat Dis. 2017;13(2):250–60.CrossRefPubMed Wang T, Zhang P, Zhang X, et al. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats. Surg Obes Relat Dis. 2017;13(2):250–60.CrossRefPubMed
13.
go back to reference Xu B, Yan X, Shao Y, et al. A comparative study of the effect of gastric bypass, sleeve gastrectomy, and duodenal–jejunal bypass on type-2 diabetes in non-obese rats. Obes Surg. 2015;25(10):1966–75.CrossRefPubMed Xu B, Yan X, Shao Y, et al. A comparative study of the effect of gastric bypass, sleeve gastrectomy, and duodenal–jejunal bypass on type-2 diabetes in non-obese rats. Obes Surg. 2015;25(10):1966–75.CrossRefPubMed
14.
go back to reference Zhang X, Yu B, Yang D, et al. Gastric volume reduction is essential for the remission of type 2 diabetes mellitus after bariatric surgery in nonobese rats. Surg Obes Relat Dis. 2016;12(8):1569–76.CrossRefPubMed Zhang X, Yu B, Yang D, et al. Gastric volume reduction is essential for the remission of type 2 diabetes mellitus after bariatric surgery in nonobese rats. Surg Obes Relat Dis. 2016;12(8):1569–76.CrossRefPubMed
15.
go back to reference Kim J. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery statement on single-anastomosis duodenal switch. Surg Obes Relat Dis. 2016;12(5):944–5.CrossRefPubMed Kim J. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery statement on single-anastomosis duodenal switch. Surg Obes Relat Dis. 2016;12(5):944–5.CrossRefPubMed
16.
go back to reference Di J, Zhang H, Yu H, et al. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m2. Surg Obes Relat Dis. 2016;12(7):1357–63.CrossRefPubMed Di J, Zhang H, Yu H, et al. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m2. Surg Obes Relat Dis. 2016;12(7):1357–63.CrossRefPubMed
17.
go back to reference Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional study. J Biomed Res. 2015;29(2):112–7.PubMedPubMedCentral Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional study. J Biomed Res. 2015;29(2):112–7.PubMedPubMedCentral
18.
go back to reference Zhao L, Li W, Su Z, et al. Preoperative fasting C-peptide predicts type 2 diabetes mellitus remission in low-BMI Chinese patients after Roux-en-Y gastric bypass. J Gastrointest Surg. 2018;22:1672–8.CrossRefPubMed Zhao L, Li W, Su Z, et al. Preoperative fasting C-peptide predicts type 2 diabetes mellitus remission in low-BMI Chinese patients after Roux-en-Y gastric bypass. J Gastrointest Surg. 2018;22:1672–8.CrossRefPubMed
19.
go back to reference da Cruz SP, Matos A, Pereira S, et al. Roux-en-Y gastric bypass aggravates vitamin A deficiency in the Mother-Child Group. Obes Surg. 2018;28(1):114–21.CrossRefPubMed da Cruz SP, Matos A, Pereira S, et al. Roux-en-Y gastric bypass aggravates vitamin A deficiency in the Mother-Child Group. Obes Surg. 2018;28(1):114–21.CrossRefPubMed
21.
go back to reference Chakhtoura M, Rahme M, El-Hajj Fuleihan G, et al. Metabolism in bariatric surgery. Endocrinol Metab Clin N Am. 2017;46(4):947–82.CrossRef Chakhtoura M, Rahme M, El-Hajj Fuleihan G, et al. Metabolism in bariatric surgery. Endocrinol Metab Clin N Am. 2017;46(4):947–82.CrossRef
22.
go back to reference Mahawar KK, Bhasker AG, Bindal V, et al. Zinc deficiency after gastric bypass for morbid obesity: a systematic review. Obes Surg. 2017;27(2):522–9.CrossRefPubMed Mahawar KK, Bhasker AG, Bindal V, et al. Zinc deficiency after gastric bypass for morbid obesity: a systematic review. Obes Surg. 2017;27(2):522–9.CrossRefPubMed
23.
go back to reference van den Broek M, de Heide LJM, Emous M, et al. Satiety and gastrointestinal hormones during a mixed meal tolerance test after gastric bypass surgery: association with plasma amino acid concentrations. Surg Obes Relat Dis. 2018;14(8):1106–17. van den Broek M, de Heide LJM, Emous M, et al. Satiety and gastrointestinal hormones during a mixed meal tolerance test after gastric bypass surgery: association with plasma amino acid concentrations. Surg Obes Relat Dis. 2018;14(8):1106–17.
24.
go back to reference de Hollanda A, Casals G, Delgado S, et al. Gastrointestinal hormones and weight loss maintenance following Roux-en-Y gastric bypass. J Clin Endocrinol Metab. 2015;100(12):4677–84.CrossRefPubMed de Hollanda A, Casals G, Delgado S, et al. Gastrointestinal hormones and weight loss maintenance following Roux-en-Y gastric bypass. J Clin Endocrinol Metab. 2015;100(12):4677–84.CrossRefPubMed
25.
go back to reference de Hollanda A, Jiménez A, Corcelles R, et al. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014;10(5):814–9.CrossRefPubMed de Hollanda A, Jiménez A, Corcelles R, et al. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014;10(5):814–9.CrossRefPubMed
26.
go back to reference Jørgensen NB, Dirksen C, Bojsen-Møller KN, et al. Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes. 2013;62(9):3044–52.CrossRefPubMedPubMedCentral Jørgensen NB, Dirksen C, Bojsen-Møller KN, et al. Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes. 2013;62(9):3044–52.CrossRefPubMedPubMedCentral
27.
go back to reference Bojsen-Møller KN. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Dan Med J. 2015;62(4):B5057.PubMed Bojsen-Møller KN. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Dan Med J. 2015;62(4):B5057.PubMed
28.
go back to reference Mingrone G, Castagneto M. Bariatric surgery: unstressing or boosting the beta-cell? Diabetes Obes Metab. 2009;11(Suppl. 4):130–42.CrossRefPubMed Mingrone G, Castagneto M. Bariatric surgery: unstressing or boosting the beta-cell? Diabetes Obes Metab. 2009;11(Suppl. 4):130–42.CrossRefPubMed
29.
go back to reference Fujitani Y. How does glucagon-like peptide 1 stimulate human beta-cell proliferation? A lesson from islet graft experiments. J Diabetes Investig. 2018;9:1255–7.CrossRefPubMedPubMedCentral Fujitani Y. How does glucagon-like peptide 1 stimulate human beta-cell proliferation? A lesson from islet graft experiments. J Diabetes Investig. 2018;9:1255–7.CrossRefPubMedPubMedCentral
30.
go back to reference Dutia R, Brakoniecki K, Bunker P, et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 2014;63(4):1214–23.CrossRefPubMedPubMedCentral Dutia R, Brakoniecki K, Bunker P, et al. Limited recovery of beta-cell function after gastric bypass despite clinical diabetes remission. Diabetes. 2014;63(4):1214–23.CrossRefPubMedPubMedCentral
Metadata
Title
Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB
Authors
Tingfeng Wang
Yunlong Shen
Zhengdong Qiao
Yueqian Wang
Peng Zhang
Bo Yu
Publication date
01-04-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-03630-5

Other articles of this Issue 4/2019

Obesity Surgery 4/2019 Go to the issue